Adial Pharmaceuticals, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adial Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2024-06-30 was $411.09K, a 692.07% increase year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2023-06-30 was $51.90K.
- Adial Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2021-12-31 was $800.00K.
- Adial Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2021-09-30 was $5.50M, a 1000.00% increase year-over-year.
- Adial Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2024 was $75.00K, a 44.50% increase from fiscal 2023.
- Adial Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2023 was $51.90K.
- Adial Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2021 was $11.75M, a 21.67% decline from fiscal 2020.
- Adial Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2020 was $15.00M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2024-12-31 | $75.00K 10-K · filed 2026-03-05 | |
| 2024-06-30 | $411.09K 10-Q · filed 2025-08-13 | |
| 2023-12-31 | $51.90K 10-K · filed 2025-03-04 | |
| 2023-06-30 | $51.90K 10-Q · filed 2024-11-13 | |
| 2021-12-31 | $800.00K derived: 10-K 12 month − 3 quarters · filed 2022-03-28 | $11.75M 10-K · filed 2022-03-28 |
| 2021-09-30 | $5.50M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $2.81M 10-Q · filed 2021-11-15 | |
| 2021-03-31 | $2.64M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $15.00M 10-K · filed 2021-03-22 | |
| 2020-09-30 | $500.00K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $4.66M 10-Q · filed 2021-11-15 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | $1.46M 10-K · filed 2020-03-20 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | |
| 2018-06-30 | $1.46M 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |